Dr. Beaupre on Ibrutinib in Marginal Zone Lymphoma - OncLive - OncLive
OncLive
Dr. Beaupre on Ibrutinib in Marginal Zone Lymphoma - OncLive
OncLive
Darrin M. Beaupre, MD, head of Early Development and Immunotherapy at Pharmacyclics, discusses a trial exploring the efficacy of ibrutinib in patients with ...and more »
Read more »